MARX Biotech Co., Ltd. (TPEX:7731)
Taiwan · Delayed Price · Currency is TWD 5.14
-0.01 (-0.19%)
Mar 20, 2026, 1:47 PM CST
MARX Biotech Market Cap
MARX Biotech has a market cap or net worth of 2.6 billion as of March 20, 2026. Its market cap has decreased by -26.92% in one year.
Market Cap
2.60B
Enterprise Value
2.94B
Revenue
712.87M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.14
Market Cap Chart
Since February 5, 2024, MARX Biotech's market cap has decreased from 4.38B to 2.60B, a decrease of -40.78%. That is a compound annual growth rate of -21.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 2.60B | 6.43% |
| Dec 31, 2025 | 2.44B | -30.65% |
| Dec 31, 2024 | 3.52B | -19.77% |
| Feb 5, 2024 | 4.38B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 239.77B |
| Caliway Biopharmaceuticals | 163.06B |
| Heron Neutron Medical | 63.85B |
| Bora Pharmaceuticals | 61.34B |
| HeXun Biosciences | 2.75B |
| PhytoHealth | 2.65B |
| 3D Global Biotech | 2.65B |
| Applied BioCode | 2.57B |